Francesco Cipollone

Mario Negri Institute for Pharmacological Research — Italy

Medicine · Health Sciences

64h-index12.4kcitations332works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(50), Inflammatory mediators and NSAID effects(47), COVID-19 Clinical Research Studies(36), Antiplatelet Therapy and Cardiovascular Diseases(25), Atherosclerosis and Cardiovascular Diseases(24)

Publications316 total

Letter by Boccatonda et al Regarding Article, “A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure”
Circulation·2025
Smart aging: integrating AI into elderly healthcare
BMC Geriatrics·2025· 4 citedOpen Access
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry
Internal and Emergency Medicine·2025
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort
Rheumatology and Therapy·2025Open Access
Circulating S100A8/A9 drives faster platelet COX-1 recovery via MRP4, impairing the duration of aspirin response
Blood Advances·2025Open Access
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study
BMC Rheumatology·2025Open Access
Perceived knowledge and attitudes toward fall prevention among nurses and healthcare assistants: a Cross-Sectional survey study
Annals of Medicine·2025Open Access
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review
Journal of Clinical Medicine·2025· 1 citedOpen Access
High cardiovascular risk patients in primary prevention and stepwise strategy in real life: Economic impact of bempedoic acid therapy in achieving the target
Atherosclerosis·2025Open Access
Could doctors reduce statin intolerance with a "DOCebo" effect?
Atherosclerosis·2025Open Access
Efficacy and safety of monoclonal antibodies against PCSK9I: Real life data
Atherosclerosis·2025
SLCO1B1 mutation is a predisposition for statin intolerance independently from FH mutation in patient with hypercholesterolemia
Atherosclerosis·2025Open Access
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes
Cardiovascular Diabetology·2025· 4 citedOpen Access
Carotid ultrasound: is it the best way to evaluate subclinical atherosclerosis?
Minerva Cardiology and Angiology·2025
Splanchnic venous thrombosis in patients with acute cholecystitis: a case series and review of literature
Journal of Ultrasound·2025· 1 citedOpen Access
Early prescription of SGLT2i for acute patient care: from current evidence to future directions
Current Problems in Cardiology·2025· 1 cited
Lung Ultrasound After COVID-19: A Pivotal Moment for Clinical Integration—Navigating Challenges and Seizing Opportunities
Healthcare·2025Open Access
Clinical characteristics and genetic predisposition of dyslipidemic patients with statin intolerance
European Atherosclerosis Journal·2025Open Access
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review
Reumatismo·2025Open Access
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
Rheumatology Advances in Practice·2025Open Access
page 1 of 16Next →

Frequent Co-authors

Andrea Mezzetti(26), Franco Cuccurullo(19), Maria Fazia(14), Annalisa Iezzi(13), Francesco Chiarelli(10), S Ucchino(10), Barbara Pini(9), Francesca Santilli(9), Chiara Cuccurullo(8), Domenico De Cesare(8), Damiano D’Ardes(8), Francesco Spigonardo(8), Marco Bucci(8), Giovanni Davı̀(7), Carlo Patrono(7), Giovanni Ciabattoni(6), Paola Patrignani(5), Raffaella Muraro(5), Tonino Bucciarelli(5), Maria R. Panara(4)